Zydus Cadila Signs Pact With Gilead To Make Remdesivir

13 June 2020

299

Drugmaker Zydus Cadila mentioned on Friday it signed a non-exclusive settlement with Gilead Sciences Inc to fabricate and market antiviral drug remdesivir, the primary remedy to indicate enchancment in COVID-19 trials.

Comments

Discover more from News Journals

Subscribe to get the latest posts sent to your email.

Previous articleभारत में कोरोना वायरस संक्रमितों की तादाद तीन लाख के पार : 10 बड़ी बातें

Next articleSmartphones That Received a Price Hike in India in the Last 1 Month

News Journals https://newsjournals.in

Zydus Cadila Signs Pact With Gilead To Make Remdesivir

Like this:

Related

Discover more from News Journals

RELATED ARTICLES

LEAVE A REPLY Cancel reply

Most Popular

Recent Comments

Share this:

Like this:

Related

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

FOLLOW US